Australia is carefully awaiting the arrival of retatrutide, a groundbreaking dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, https://carapdqh618370.ktwiki.com/2476424/retatrutide_australia_a_new_solution_for_weight_management